搜索筛选:
搜索耗时4.0157秒,为你在为你在102,285,761篇论文里面共找到 6 篇相符的论文内容
类      型:
[会议论文] 作者:Jiang Haibing,Li Lan,Li Xiufeng,Ma Jun,Mao Lati,Xu Fengyan,Jiang Shubin, 来源:第十二届中国介入心脏病学大会(CIT2014) 年份:2014
[会议论文] 作者:Li Lan,Jiang Haibing,Li Xiufen,Mao Lati,Ma Jun,Xu Fengyan,Jiang Shubin, 来源:第十二届中国介入心脏病学大会(CIT2014) 年份:2014
[会议论文] 作者:Jiang Haibing,Li Lan,Li Xiu-fen,Mao Lati,Ma Jun,Xu Fengyan,Jiang Shubin, 来源:第十二届中国介入心脏病学大会(CIT2014) 年份:2014
[会议论文] 作者:Jiang Haibing,Li Lan,Li Xiufeng,Ma Jun,Mao Lati,Xu Fengyan,Jiang Shubin, 来源:第十二届中国介入心脏病学大会(CIT2014) 年份:2014
Background Statin therapy maybe increased the risk of development of diabetes in patients.We investigated glucose and lipid metabolism in acute coronary syndrome patients with impaired glucose toleran...
[会议论文] 作者:Li Lan,Jiang Haibing,Li Xiufen,Mao Lati,Ma Jun,Xu Fengyan,Jiang Shubin, 来源:第十二届中国介入心脏病学大会(CIT2014) 年份:2014
Background Compliance rate of blood lipids are not satisfied when we used only statin therapy,we deserve the influence of the rosuvastatin combined with ezetimibe to glucose and lipid metabolism of th...
[会议论文] 作者:Jiang Haibing,Li Lan,Li Xiu-fen,Mao Lati,Ma Jun,Xu Fengyan,Jiang Shubin, 来源:第十二届中国介入心脏病学大会(CIT2014) 年份:2014
Background Rivaroxaban is a direct inhibitor of factor Xa,in treatment of orthopedic surgery and atrial fibrillation it could decrease embolic events.We studied curative effect and safety of rivaroxab...
相关搜索: